Accelerating the integration of China into the global development of innovative anticancer drugs.
Huang H, Wu D, Miao H, Tang Y, Liu C, Fang H, Meng X, Wang S, Zhu Q, Wang X, Du J, Yang Z, Li N, Xu B, He J.
Huang H, et al. Among authors: wang x, wang s.
Lancet Oncol. 2022 Nov;23(11):e515-e520. doi: 10.1016/S1470-2045(22)00483-1.
Lancet Oncol. 2022.
PMID: 36328025
Review.